Press release content from PR Newswire. The AP news staff was not involved in its creation.
Joerns Healthcare Selected by Bristol Hospice as Sole Source Medical Equipment Service Partner
April 15, 2021 GMT
Joerns Healthcare (PRNewsFoto/Joerns Healthcare)
CHARLOTTE, N.C., April 15, 2021 /PRNewswire/ Joerns Healthcare, LLC, a leading medical equipment services company to the care continuum, announced today that they have entered into a sole source agreement with Bristol Hospice, LLC. Joerns Healthcare’s hospice integrated business system was a key value-driver for the agreement. The pairing of Joerns Healthcare’s capability as an integrated service provider and manufacturer to provide standardized products and services in a timely, customer-centric manner, with Bristol, one of the fastest growing hospice agencies in the country with a reputation for exceptional patient and family services, is seen as a powerful partnership.
Press release content from Business Wire. The AP news staff was not involved in its creation.
GenScript Biotech BV and IES Diagnostics Forge Distribution Agreement for SARS-CoV-2 Neutralizing Antibody Kit
April 14, 2021 GMT
LEIDEN, Netherlands & BILBAO, Spain (BUSINESS WIRE) Apr 14, 2021
ADVERTISEMENT
The test measures the presence of neutralizing antibodies (NAbs) in patients recovering from COVID-19 or receiving a vaccine. It is the only U.S. FDA Emergency Use Authorized (EUA) serology test for neutralizing antibodies from recent and prior SARS-CoV-2 infections. The kit is also CE marked (Europe) and has received HSA provisional approval (Singapore), ANVISA in Brazil, ANMAT in Argentina and has recently received clearance from the Ministry of Health and Prevention (MOHAP) in the United Arab Emirates as a medical device.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Claritas Announces Letter of Intent to Acquire Exclusive Worldwide Rights to Develop R-107 for PAH
Claritas Pharmaceuticals, Inc.April 14, 2021 GMT
SAN FRANCISCO and TORONTO, April 14, 2021 (GLOBE NEWSWIRE) Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the “Company” or “Claritas”) today announced that it has entered into a binding Letter of Intent (the “LOI”) with Salzman Group, Inc. (a Delaware corporation), Salzman Group, Ltd. (an Israeli corporation), and Salzman Group Pty. Ltd. (an Australian corporation), (collectively, the “Salzman Group”), under which Salzman Group will grant to Claritas an exclusive, worldwide license to develop and commercialize R-107 for the treatment of pulmonary arterial hypertension (“PAH”). The Company expects that definitive agreements will be executed by May 15, 2021. Closing of the transaction is subject to rece
Press release content from Business Wire. The AP news staff was not involved in its creation.
Kyoto Semiconductor Signs Supply and Reseller Agreement With CEL
April 13, 2021 GMT
TOKYO (BUSINESS WIRE) Apr 12, 2021
Kyoto Semiconductor Co., Ltd., a leading optical device solution manufacturer with world-class technologies and Japanese quality, has announced that it has entered into an agreement with California Eastern Laboratories (CEL) to be a multinational reseller of Kyoto Semiconductor’s optical device solutions.
The partnership extends Kyoto Semiconductor’s sales and support network not only to North America but to countries such as India and Israel while it enhances CEL’s product offering with Kyoto Semiconductor’s high-quality photodiodes for optical communication and sensing equipment
Press release content from PR Newswire. The AP news staff was not involved in its creation.
KBR Expands Support to UK Naval Defence
April 12, 2021 GMT
HOUSTON, April 12, 2021 /PRNewswire/ KBR (NYSE: KBR) is expanding its presence in the UK naval defense sector with a new five year $470m contract to bring transformational change to the delivery of infrastructure services at HM Naval Base Portsmouth.
KBR, working in a joint venture with BAE Systems, under the name KBS Maritime, will deliver ambitious, modern and enduring change to the Portsmouth base, securing investment in the local community and ensuring fit-for-purpose, world-leading support for the Royal Navy over the next five years.